These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 193238)

  • 21. Comparative studies on growth of foot-and-mouth disease virus types 0 and Asia 1 in BHK-21 Razi cells.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1986 Sep; 30(5):367-72. PubMed ID: 2878583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro.
    Acosta EG; Bruttomesso AC; Bisceglia JA; Wachsman MB; Galagovsky LR; Castilla V
    Virus Res; 2008 Aug; 135(2):203-12. PubMed ID: 18462821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the antiviral action of the newly synthetized compound F-VMI-15 on the reproduction of influenza virus type A2 (Hong Kong) 68 in cell cultures].
    Gagov I; Uzunova A; Georgiev G; Drianovska L
    Izv Mikrobiol Inst (Sofiia); 1972; 23():129-33. PubMed ID: 4663870
    [No Abstract]   [Full Text] [Related]  

  • 24. [On testing the efficiency of foot-and-mouth disease hyperimmune serum in guinea pigs by injecting myotropic foot-and-mouth disease virus strains].
    Bengelsdorff HJ
    Zentralbl Veterinarmed B; 1965 Jul; 12(4):340-50. PubMed ID: 4283976
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of alkylating agents for the inactivation of foot-and-mouth disease virus and the preparation of a new inactivated vaccine].
    Durand M; Guilloteau B; Giraud M; Guerche M; Pesson M; Prunet P
    Bull Off Int Epizoot; 1968; 69(3):429-65. PubMed ID: 4303692
    [No Abstract]   [Full Text] [Related]  

  • 26. Actinomycetes activity against foot and mouth disease virus determined by a new method.
    De Banchero EP; Goyena JG; Cercos AP
    J Antibiot (Tokyo); 1965 Jul; 18(4):195. PubMed ID: 4285352
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural analysis of foot-and-mouth disease virus 3C protease: a viable target for antiviral drugs?
    Curry S; Roqué-Rosell N; Sweeney TR; Zunszain PA; Leatherbarrow RJ
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):594-8. PubMed ID: 17511659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
    Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preadsorption of boar semen with kaolin: increased efficiency of foot-and-mouth disease virus detection.
    Richmond JY
    Am J Vet Res; 1978 Oct; 39(10):1612-6. PubMed ID: 213994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of replication of foot-and-mouth disease virus in infected cells].
    Shestochenko MA; Karev VP; Rostovtseva IA; Chernyshova GT
    Veterinariia; 1968 Jul; 45(7):22-3. PubMed ID: 4310522
    [No Abstract]   [Full Text] [Related]  

  • 32. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Foot-and-mouth disease virus replication in cloned BHK-21 cell cultures with reduced serum requirements].
    Latzke W; Wagner S; Dauber M; Holl H
    Arch Exp Veterinarmed; 1987 Nov; 41(6):797-801. PubMed ID: 2831826
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protective effect in the serum of rabbits inoculated with BHK-21 cells infected with foot-and-mouth disease virus].
    Brunengo AM; Massouh EJ; Ubogui JL
    Rev Argent Microbiol; 1979; 11(1):14-21. PubMed ID: 231797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of viruses by aziridines.
    Burrage T; Kramer E; Brown F
    Dev Biol (Basel); 2000; 102():131-9. PubMed ID: 10794100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia].
    Gómez GJ; Doel TR
    Rev Latinoam Microbiol; 1984; 26(1):21-6. PubMed ID: 6091209
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus.
    Kleina LG; Grubman MJ
    J Virol; 1992 Dec; 66(12):7168-75. PubMed ID: 1331517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of zinc and other chemical agents on foot-and-mouth-disease virus replication.
    Polatnick J; Bachrach HL
    Antimicrob Agents Chemother; 1978 May; 13(5):731-4. PubMed ID: 208461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of divinyl ether-maleic anhydride (pyran) on foot-and-mouth disease virus infection: effect on adsorption and multiplication in mouse tissues.
    Richmond JY; Campbell CH
    Arch Gesamte Virusforsch; 1972; 36(3):232-9. PubMed ID: 4336491
    [No Abstract]   [Full Text] [Related]  

  • 40. [New compound possessing a chemotherapeutic action with regard to experimental infection of the guinea pig by foot-and-mouth disease virus].
    Dhennin L; Sy M; Maillet M; Dhennin L
    C R Acad Hebd Seances Acad Sci D; 1966 Apr; 262(15):1657-60. PubMed ID: 4956355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.